Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | PSMB5 | P28074 | 4/20 | 0.36 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.35 |
| ▸ | NQO1 | P15559 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9764845 | 0.85 | MAOB (0.42) | MAOBHSD17B2KMT2AMAPTPSMB5 | |
| SCHEMBL9764925 | 0.82 | ALOX5 (0.45) | MAOBHSD17B2KMT2AMAPTPSMB5 | |
| SCHEMBL9764826 | 0.80 | MAOB (0.40) | MAOBHSD17B2KMT2APSMB5PSMB8 | |
| SCHEMBL10593685 | 0.77 | MAOB (0.41) | MAOBHSD17B2KMT2AADORA2B | |
| SCHEMBL9764812 | 0.75 | ALOX5 (0.50) | TP53HSD17B2MAPTALDH1A1 | |
| SCHEMBL9764828 | 0.72 | MAOB (0.40) | MAOBMAPTPSMB5HPGD | |
| SCHEMBL10561811 | 0.71 | ALOX5 (0.43) | MAOBHSD17B2KMT2APSMB5PSMB8 | |
| SCHEMBL4139411 | 0.71 | MAOB (0.45) | MAOBTP53HSD17B2KMT2APSMB5 | |
| SCHEMBL9764903 | 0.70 | MAOB (0.42) | MAOBTP53MAPTPSMB5PSMB8 | |
| SCHEMBL4146586 | 0.70 | MAOB (0.44) | MAOBHSD17B2PSMB5PSMB8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0422079-A4 | TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE | — | 1991-08-21 | — | — | EP | disclosed |
| EP-0422079-A1 | TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE | ABBOTT LABORATORIES (US) | 1991-04-17 | — | — | EP | disclosed |
| WO-1989012636-A1 | TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE | ABBOTT LABORATORIES (US) | 1989-12-28 | — | — | WO | disclosed |